CNRS Technologies

Find the best CNRS technologies to boost your innovative project.

Les brevets les plus récents

You are a research scientist?

We can guide you through the whole technology transfer process.

See all our services

You are a corporate player?

Thanks to our expertise, our network and our know-how of the innovation ecosystem, we support you throughout your project.

Contact us

Follow our news and upcoming events

Discover CNRS technologies

Meet our team

Fermer

Murine hybridoma secreting monoclonal antibody anti-DcR1

Référence

86445-01

Inventeurs

Jean-Luc TAUPIN
Sophie DABURON

Statut commercial

Non-exclusive know-how licenses

Laboratoire

This invention has been developed at the “Composantes innées de la réponse immunitaire et différenciation” laboratory, a CNRS laboratory (UMR5164), in the Victor Segalen university, BORDEAUX 2, France.

Description

TECHNICAL DESCRIPTION

The present invention relates to a murine hybridoma secreting a monoclonall antibody targeting human DcR1. DcR1 is a receptor of the TRAIL receptors family, which are belong to the apoptosis-inducing members of the Tumor Necrosis Factor (TNF) receptor superfamily. DcR1 behaves as a decoy receptor inhibiting TRAIL-mediated cell death in several cellular systems.

The inventors also developed a control cell line which over expresses a c-myc-tagged chimeric membrane DcR1 protein and so can be used to test the specificity of the produced antibody.

INDUSTRIAL APPLICATIONS

This innovation could be used as a research reagent for the study of TRAIL-mediated apoptosis and its control by DcR1.

It can also be used for phenotyping normal and abnormal human cells and cell lines.

For further information, please contact us (Ref 86445-01)

 


Besoin de plus d'informations ?

Nous contacter
Fermer

Contactez-nous

  • This field is for validation purposes and should be left unchanged.
Fermer

Les brevets les plus récents